about
An evidence-based algorithm for the treatment of neuropathic painStatins and peripheral neuropathyEfficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.Pharmacotherapy of trigeminal neuralgia.The evidence for pharmacological treatment of neuropathic pain.Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine.Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.Antidepressants in the treatment of neuropathic pain.The clinical picture of neuropathic pain.EFNS guidelines on pharmacological treatment of neuropathic pain.Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsAlgorithm for neuropathic pain treatment: an evidence based proposal.Chronic neuropathic pain: mechanisms, drug targets and measurement.Spontaneous temporal changes and variability of peripheral nerve conduction analyzed using a random effects model.Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study.Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial.The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.Randomized controlled trial of the combined monoaminergic and opioid investigational compound GRT9906 in painful polyneuropathy.A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C).The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.Recent advances in pharmacological treatment of neuropathic painLevetiracetam in spinal cord injury pain: a randomized controlled trial.Effect of levetiracetam on the postmastectomy pain syndrome.Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial.Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial.Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion.TDM-based imipramine treatment in neuropathic pain.Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.St. John's wort has no effect on pain in polyneuropathy.The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels.Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study.Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms.Quantitative sensory testing using DFNS protocol in Europe: an evaluation of heterogeneity across multiple centers in patients with peripheral neuropathic pain and healthy subjects.Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic, and -genetic aspects.Who is healthy? Aspects to consider when including healthy volunteers in QST--based studies-a consensus statement by the EUROPAIN and NEUROPAIN consortia.Role of genetic polymorphism in psychopharmacology--an update.The pharmacogenetics of codeine hypoalgesia.
P50
Q24680820-51B5353A-82DE-44AF-9DC1-B0BEE43EDA3CQ28157385-C1240E80-3092-441F-863B-EA056383598AQ33777417-C2B79837-EB49-4D04-92D4-9597A146315AQ34110447-5ED424C0-D3DE-41BA-A99A-312B8EBE1668Q34130946-9AEECFC3-B5FB-4338-987F-B0B8D5127D03Q34228651-F09C9495-E4C5-40D9-ADBF-DD870102621CQ34357347-8A635F72-29C9-47C0-BF82-914B9D4C691BQ34420689-B6120FA8-6C0A-4F40-B214-7C9B2E82C3DEQ34430594-20709CB2-1ED2-41D5-9721-8483BA9B7D00Q34573607-5FC10EC0-51CF-4E58-B7B0-7458A29299A2Q34950507-3EC55083-AEC3-477A-AE17-A1E0C4D87A14Q35846608-AF5FD9E9-DA58-4FA1-AB6E-96D2183C60B8Q36280904-00767982-0AFF-43C1-AD89-6A3D5906DB6FQ36772936-9D35A6E8-E1D1-4CEF-BAE6-FA54C3E8A6A7Q39149999-35408030-1E9F-452A-B133-8532C266F57FQ39187661-562CEA8D-3870-41FA-89D5-5AE97A178912Q39193489-F35137C7-F152-45D0-BC95-7270017EBD4AQ39202304-2A6515DF-59F0-4F3D-9B88-F083CE4B9C96Q39251767-F55303BA-398D-43BA-BF66-188E03A28B77Q39251785-A9CD747C-53AA-496D-B9B4-DCD624FC5FB1Q39265337-736EC16F-C830-48BB-8FBF-7CDAE557EF91Q39274579-E1D06CAC-80EB-474C-BA62-C958ADB8E298Q39274866-E3EBD79E-B0DC-44FE-87C9-F1E10A325CEEQ39302571-E9C9B748-9F56-45F4-B24F-459A61AF9824Q39318202-902D73D3-579E-4E68-A7C3-EB9F0482C764Q39318526-2AF23EBE-651B-4DA6-A19E-D0C8109D94D8Q39367828-63744DC0-B756-438C-8C3B-8E95A247B221Q39378050-D861321E-C076-4E71-9088-CF59D4432E01Q39378393-56E109A1-3EC5-400D-9223-8E57CF4616F0Q39395734-D6C19231-8154-48BA-A8E5-5DF58CA3D950Q39420482-2B8E5B3D-2E5A-46FC-B061-89393BD1E123Q39433907-6FFC59DB-3C44-49A6-BACF-9694D1C6D0D4Q39436068-DB5A55FF-2E5A-414A-A887-5CDF41A37E03Q39507635-28517975-97E3-488F-9DBA-6253ABAA99FAQ39518017-B36D497E-66FF-4535-8729-97C945187D47Q40249180-FA5094EB-CC22-45E6-AF92-EC56378EEB6BQ40754747-6BECBFDA-C6BB-4F88-992B-4CACB9A19F94Q40834323-B907139E-19A1-4CF5-98A7-DEE5E6C930A5Q40840711-A5EB4C9F-927F-4DBC-8185-B71967E36E90Q41142865-1694F12D-D6FF-452B-8CE3-681840428321
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Søren H Sindrup
@ast
Søren H Sindrup
@en
Søren H Sindrup
@es
Søren H Sindrup
@nl
Søren H Sindrup
@sl
type
label
Søren H Sindrup
@ast
Søren H Sindrup
@en
Søren H Sindrup
@es
Søren H Sindrup
@nl
Søren H Sindrup
@sl
altLabel
Søren Sindrup
@en
prefLabel
Søren H Sindrup
@ast
Søren H Sindrup
@en
Søren H Sindrup
@es
Søren H Sindrup
@nl
Søren H Sindrup
@sl
P106
P21
P31
P496
0000-0003-0357-8628